ArticleComputers in biology and medicine2026
Influence of CT harmonization in longitudinal radiomics for NSCLC immunotherapy response prediction.
Article in Computers in biology and medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Foundation model-enhanced multimodal radiomics for predicting response to chemo-immunotherapy in advanced lung squamous cell carcinoma.Frontiers in oncology · 2026Article
- Medical imaging in immunotherapy response evaluation: from RECIST to AI-driven longitudinal models, and the distinction between risk prediction and kinetic diagnosis.Frontiers in medicine · 2026Review
- Causal AI for cancer immunotherapy: a narrative framework review of target trial emulation, treatment-effect learning and clinical translation.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
This study investigates the variability of radiomic features in longitudinal CT scans from a multi-institutional NSCLC cohort and introduces a harmonization pipeline to improve predictive modeling of immunotherapy response. Baseline and follow-up CT scans from NSCLC patients treated with anti-PD-1/PD-L1 agents were analyzed, with two institutions combined for model training and internal testing, and a third institution serving as an external test set. To address variability from imaging parameters-such as scanner manufacturer, slice thickness, and noise-we applied image harmonization followed by feature harmonization using NestedComBat. This approach substantially reduced feature dependence on acquisition confounders (from 78.8% to 12.8%) and improved feature robustness across institutions. We further assessed the temporal consistency of radiomic features across longitudinal scans using the intraclass correlation coefficient (ICC). Image harmonization yielded the largest gains in stability (mean ΔICC = +0.021, p < 0.001), while the combined approach also enhanced longitudinal reliability (ΔICC = +0.014, p < 0.001). Finally, harmonization improved predictive performance for 6-month immunotherapy response, increasing the AUC from 0.695 to 0.768 in the internal test and from 0.692 to 0.802 in the external test. These results demonstrate that combining image- and feature-level harmonization enhances the robustness and temporal consistency of radiomic features, potentially supporting more reliable and generalizable predictive modeling across diverse datasets and clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.